Privia Health Group Inc. (PRVA)
Privia Health Statistics
Share Statistics
Privia Health has 120.51M shares outstanding. The number of shares has increased by 1% in one year.
Shares Outstanding | 120.51M |
Shares Change (YoY) | 1% |
Shares Change (QoQ) | 0.43% |
Owned by Institutions (%) | 99.99% |
Shares Floating | 106.72M |
Failed to Deliver (FTD) Shares | 136 |
FTD / Avg. Volume | 0.02% |
Short Selling Information
The latest short interest is 5.73M, so 4.78% of the outstanding shares have been sold short.
Short Interest | 5.73M |
Short % of Shares Out | 4.78% |
Short % of Float | 5.39% |
Short Ratio (days to cover) | 8.83 |
Valuation Ratios
The PE ratio is undefined and the forward PE ratio is 25.86. Privia Health's PEG ratio is undefined.
PE Ratio | undefined |
Forward PE | 25.86 |
PS Ratio | 1.34 |
Forward PS | 0.9 |
PB Ratio | 3.68 |
P/FCF Ratio | undefined |
PEG Ratio | undefined |
Enterprise Valuation
Privia Health Group Inc. has an Enterprise Value (EV) of 2.31B.
EV / Earnings | 160.38 |
EV / Sales | 1.33 |
EV / EBITDA | 95.14 |
EV / EBIT | 135.86 |
EV / FCF | 21.11 |
Financial Position
The company has a current ratio of 1.86, with a Debt / Equity ratio of undefined.
Current Ratio | 1.86 |
Quick Ratio | 1.86 |
Debt / Equity | undefined |
Total Debt / Capitalization | 0.87 |
Cash Flow / Debt | 19.55 |
Interest Coverage | undefined |
Financial Efficiency
Return on equity (ROE) is 0.02% and return on capital (ROIC) is 1.51%.
Return on Equity (ROE) | 0.02% |
Return on Assets (ROA) | 0.01% |
Return on Capital (ROIC) | 1.51% |
Revenue Per Employee | $1,523,149.12 |
Profits Per Employee | $12,618.42 |
Employee Count | 1,140 |
Asset Turnover | 1.53 |
Inventory Turnover | n/a |
Taxes
Income Tax | 10.83M |
Effective Tax Rate | 0.39 |
Stock Price Statistics
The stock price has increased by 17.89% in the last 52 weeks. The beta is 0.85, so Privia Health's price volatility has been higher than the market average.
Beta | 0.85 |
52-Week Price Change | 17.89% |
50-Day Moving Average | 23.74 |
200-Day Moving Average | 20.44 |
Relative Strength Index (RSI) | 38.58 |
Average Volume (20 Days) | 746.15K |
Income Statement
In the last 12 months, Privia Health had revenue of 1.74B and earned 14.38M in profits. Earnings per share was 0.12.
Revenue | 1.74B |
Gross Profit | 176.85M |
Operating Income | 16.98M |
Net Income | 14.38M |
EBITDA | 24.25M |
EBIT | 16.98M |
Earnings Per Share (EPS) | 0.12 |
Balance Sheet
The company has 491.15M in cash and 5.59M in debt, giving a net cash position of 485.56M.
Cash & Cash Equivalents | 491.15M |
Total Debt | 5.59M |
Net Cash | 485.56M |
Retained Earnings | -179.23M |
Total Assets | 1,135.8B |
Working Capital | 385.68B |
Cash Flow
In the last 12 months, operating cash flow was 109.28M and capital expenditures 0, giving a free cash flow of 109.28M.
Operating Cash Flow | 109.28M |
Capital Expenditures | 0 |
Free Cash Flow | 109.28M |
FCF Per Share | 0.92 |
Margins
Gross margin is 10.19%, with operating and profit margins of 0.98% and 0.83%.
Gross Margin | 10.19% |
Operating Margin | 0.98% |
Pretax Margin | 1.61% |
Profit Margin | 0.83% |
EBITDA Margin | 1.4% |
EBIT Margin | 0.98% |
FCF Margin | 6.29% |
Dividends & Yields
PRVA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | 0.54% |
FCF Yield | 4.05% |
Analyst Forecast
The average price target for PRVA is $26, which is 16% higher than the current price. The consensus rating is "Buy".
Price Target | $26 |
Price Target Difference | 16% |
Analyst Consensus | Buy |
Analyst Count | 16 |
Scores
Altman Z-Score | 0.19 |
Piotroski F-Score | 6 |